Connection
Barbara Frederick to Neoplasm Transplantation
This is a "connection" page, showing publications Barbara Frederick has written about Neoplasm Transplantation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.016 |
|
|
|
-
Gustafson DL, Frederick B, Merz AL, Raben D. Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts. Cancer Chemother Pharmacol. 2008 Feb; 61(2):179-88.
Score: 0.016